Please assess the completion status of the following clinical trial:

Trial Title: Choroidal Thickness in Optic Neuropathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* age greater than 18 years,~* diagnosis of optic neuropathy,~* willing and able to sign an informed consent.~Exclusion criteria:~* steroid use within the past 4 weeks,~* inability to cooperate with optical coherence tomography (OCT) testing,~* relevant ocular comorbidities in the affected or unaffected eye, such as~  * glaucoma,~ * uveitis,~ * optic nerve hypoplasia,~ * age related macular degeneration,~ * refractive error greater than 5 spherical diopters.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).